`
`Application Number:
`
`63257024
`
`International Application Number:
`
`Confirmation Number:
`
`5661
`
`
`
`arcane
`
`Title of Invention:
`
`DEGRADANT COMPOUND IN A MEDICAMENT
`
`a
`
`Paymentinformation:
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpaymentas follows:
`
`
`
`File Listing:
`
`Multi
`File Size(Bytes)/
`DocumentDescription
`Document
`Pages
`
`Number MessageDigest|Part/.zipP
`
`(if appl.)
`189796
`
`Miscellaneous Incoming Letter
`
`2021-10-18-Miscellaneous-
`
`Letter-4902-0120001.pdf
`
`523dcaScOb8bbc092dba864fl e84740a62e
`97e4e
`
`Authorization for Extension of Timeall
`
`replies
`
`
`Power of Attorney
`
`2021-10-18-
`POA-82A-4902-0120001.PDF
`
`104686
`
`900bf4d9a364acac4c09174ea665C9e5c976
`823
`
`519272
`
`c0b07cObfc1 c9cbce14e45850be4a2e4fb6el
`balc
`
`2021-10-18-EOT-
`Authorization-4902-0120001.
`
`1820a
`
`Information:
`
`Information:
`
`Information:
`
`Information:
`
`Information:
`
`Information:
`
`Power of Attorney
`
`2021-10-18-
`POA-82B-4902-0120001.PDF
`
`1b84956375e3197caa636458ea0f2c217<8¢q
`
`207888
`
`Provisional Cover Sheet (SB16)
`
`2048316
`
`2021-10-18-Provisional-
`
`Application-Cover-
`Sheet-4902-0120001.PDF
`
`d6a397aa79406affdc8466406428ed62897
`d5c33
`
`Application Data Sheet
`
`2021-10-18-
`ADS-4902-0120001.PDF
`
`6fd90c178a8d46a5a4d77079b24f5c08061
`
`1255733
`
`
`
`514473
`
`2021-10-18-Provisional-
`Application-4902-0120001.pdf 57142bcda3e1 66e1 da92ac9c33d8a2909d8}
`70d 1F
`
`ee
`
`Multipart Description/PDF files in .zip description
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`AcknowledgementReceiptwill establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptanceof the application as a
`national stage submission under35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shownon this AcknowledgementReceiptwill establish the international filing date of
`
`Information:
`
`Information:
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`e5b37aa9d9170d8735b9fe7d5d8a824e4c0}
`5811b
`
`This AcknowledgementReceipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`